Trial Profile
An observational, single-centre, retrospective analysis to evaluate darunavir/cobicistat monotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2017
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 02 Jan 2017 New trial record